Special pharmacokinetics of fluconazole in septic, obese and burn patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1439-0507|42|S2|87-90

ISSN： 0933-7407

Source： MYCOSES (ELECTRONIC), Vol.42, Iss.S2, 1999-12, pp. : 87-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics of doripenem during high volume hemodiafiltration in patients with septic shock

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 4, 2015-04 ,pp. : 438-446

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of Vancomycin in Extremely Obese Patients with Suspected or Confirmed Staphylococcus aureus Infections

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 2, 2015-02 ,pp. : 127-139

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of sequential intravenous and enteral fluconazole in critically ill surgical patients with invasive mycoses and compromised gastro-intestinal function

By Buijk S.L.C.E.   Gyssens I.C.   Mouton J.W.   Verbrugh H.A.   Touw D.J.   Bruining H.A.  

Intensive Care Medicine, Vol. 27, Iss. 1, 2001-01 ,pp. : 115-121

Springer Publishing Company

Access to resources Recommend Favorite

Population pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese and nonobese patients

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 8, 2015-08 ,pp. : 899-908

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non-obese patients with type 2 diabetes and prediabetic subjects: distinct phenotypes requiring special diabetes treatment and (or) prevention?

By Vaag Allan   Lund Søren S.  

Applied Physiology, Nutrition, and Metabolism, Vol. 32, Iss. 5, 2007-10 ,pp. : 912-920

NRC Research Press

Access to resources Recommend Favorite